Beijnen JH - Search Results

1

Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.

de Vries NA, Bruggeman SW, Hulsman D, de Vries HI, Zevenhoven J, Buckle T, Hamans BC, Leenders WP, Beijnen JH, van Lohuizen M, Berns AJ, van Tellingen O. de Vries NA, et al. Among authors: beijnen jh. Clin Cancer Res. 2010 Jul 1;16(13):3431-41. doi: 10.1158/1078-0432.CCR-09-3414. Epub 2010 May 14. Clin Cancer Res. 2010. PMID: 20472681 Free article.

2

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P. Zaman GJ, et al. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7690-4. doi: 10.1073/pnas.92.17.7690. Proc Natl Acad Sci U S A. 1995. PMID: 7644478 Free PMC article.

3

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.

Bardelmeijer HA, Ouwehand M, Malingré MM, Schellens J, Beijnen JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2002 Feb;49(2):119-25. doi: 10.1007/s00280-001-0394-2. Epub 2001 Nov 20. Cancer Chemother Pharmacol. 2002. PMID: 11862425

4

Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.

Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JH, Beijnen JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Cancer Res. 2002 Nov 1;62(21):6158-64. Cancer Res. 2002. PMID: 12414642

5

Metabolism of paclitaxel in mice.

Bardelmeijer HA, Oomen IA, Hillebrand MJ, Beijnen JH, Schellens JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Anticancer Drugs. 2003 Mar;14(3):203-9. doi: 10.1097/00001813-200303000-00003. Anticancer Drugs. 2003. PMID: 12634614

6

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

Kemper EM, van Zandbergen AE, Cleypool C, Mos HA, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: beijnen jh. Clin Cancer Res. 2003 Jul;9(7):2849-55. Clin Cancer Res. 2003. PMID: 12855665

7

The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice.

Kemper EM, Cleypool C, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2004 Feb;53(2):173-8. doi: 10.1007/s00280-003-0720-y. Epub 2003 Nov 7. Cancer Chemother Pharmacol. 2004. PMID: 14605863

8

Development and validation of a method to determine the unbound paclitaxel fraction in human plasma.

van den Bongard HJ, Kemper EM, van Tellingen O, Rosing H, Mathôt RA, Schellens JH, Beijnen JH. van den Bongard HJ, et al. Among authors: beijnen jh. Anal Biochem. 2004 Jan 1;324(1):11-5. doi: 10.1016/j.ab.2003.07.024. Anal Biochem. 2004. PMID: 14654039

9

Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.

Bardelmeijer HA, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Invest New Drugs. 2004 Aug;22(3):219-29. doi: 10.1023/B:DRUG.0000026248.45084.21. Invest New Drugs. 2004. PMID: 15122069

10

A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.

Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP. Rademaker-Lakhai JM, et al. Among authors: beijnen jh. Clin Cancer Res. 2004 May 15;10(10):3386-95. doi: 10.1158/1078-0432.CCR-03-0315. Clin Cancer Res. 2004. PMID: 15161693 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,513 results

Search Page